Valuation: OrganiGram Holdings Inc

Market Cap 190M 134M 118M 108M 101M 12.59B 194M 1.3B 505M 6.21B 501M 491M 21.6B P/E 2026 *
10.4x
P/E 2027 * 33.8x
Enterprise Value 190M 134M 118M 108M 101M 12.59B 194M 1.3B 505M 6.21B 501M 491M 21.6B EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.43x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2026-01-14
Director of Finance/CFO - 2024-01-07
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 2018-03-28
Director/Board Member 56 2018-12-16
Director/Board Member 70 2018-12-16
Change 5-day change 1-year change 3-year change Capi.($)
-1.06%-9.65% - - 134M
-3.12%-5.49%+9.93%+82.35% 108M
0.00%-16.98%+51.72%-29.03% 89.31M
+0.02%-5.29%+52.71%-15.37% 87.89M
-0.44%+17.84%-39.64%-53.35% 57.98M
Average -0.92%-2.48%+18.68%-3.85% 85.69M
Weighted average by Cap. -1.05%-4.49%+23.40%+5.32%

Financials

2026 *2027 *
Net sales 340M 239M 210M 194M 181M 22.49B 346M 2.33B 902M 11.1B 896M 876M 38.6B 441M 310M 273M 252M 235M 29.2B 449M 3.02B 1.17B 14.4B 1.16B 1.14B 50.11B
Net income 18.88M 13.27M 11.68M 10.77M 10.07M 1.25B 19.23M 129M 50.14M 617M 49.8M 48.72M 2.15B 6.53M 4.59M 4.04M 3.73M 3.49M 433M 6.65M 44.78M 17.35M 213M 17.23M 16.86M 742M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-